Insidertrades

Relmada Therapeutics

RLMD

Insider trades and stock quote 2024-2026

All insider trades at Relmada Therapeutics

Subscribe RSS
Date Type Insider Position Ø-Price Volume
12/15/2025 Buy Shenouda, Maged Chief Financial Officer $4.1 $48,060
12/15/2025 Buy Traversa, Sergio Chief Executive Officer $4.1 $113,300
11/5/2025 Buy Kelly, Paul Edward Chief Operating Officer $2.2 $198,000
11/5/2025 Buy Shenouda, Maged Chief Financial Officer $2.2 $1,100,000
11/5/2025 Buy Traversa, Sergio Chief Executive Officer $2.2 $599,500
11/5/2025 Buy Ence, Chuck CAO and COO $2.2 $299,200
8/28/2025 Buy Traversa, Sergio Chief Executive Officer $0.7 $41,422
8/27/2025 Buy Traversa, Sergio Chief Executive Officer $0.7 $86,735
8/26/2025 Buy Traversa, Sergio Chief Executive Officer $0.6 $49,938
5/20/2025 Buy Traversa, Sergio Chief Executive Officer $0.6 $82,246
5/20/2025 Buy Shenouda, Maged Chief Financial Officer $0.5 $31,422
5/19/2025 Buy Traversa, Sergio Chief Executive Officer $0.5 $14,994
5/19/2025 Buy Shenouda, Maged Chief Financial Officer $0.5 $43,686
5/16/2025 Buy Traversa, Sergio Chief Executive Officer $0.4 $77,472
5/16/2025 Buy Ence, Chuck CA and CO $0.5 $103,330
5/16/2025 Buy Shenouda, Maged Chief Financial Officer $0.4 $22,100
5/16/2025 Buy Kelly, Paul Edward Chief Operating Officer $0.4 $86,060
9/11/2024 Buy Shenouda, Maged Chief Financial Officer $3.0 $71,154
9/11/2024 Buy Traversa, Sergio Chief Executive Officer $3.0 $153,707
9/10/2024 Buy Shenouda, Maged Chief Financial Officer $2.7 $57,652
9/10/2024 Buy Traversa, Sergio Chief Executive Officer $2.8 $90,789
9/9/2024 Buy Kelly, Paul Edward Director $2.6 $64,750
9/9/2024 Buy Shenouda, Maged Chief Financial Officer $2.6 $20,895
9/9/2024 Buy Casamento, Charles J. Director $2.6 $33,280
9/9/2024 Buy Traversa, Sergio Chief Executive Officer $2.7 $150,619
Rows per page:
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)